journal article·2015-11

Regulating the surface poly(ethylene glycol) density of polymeric nanoparticles and evaluating its role in drug delivery in vivo

Xiao-Jiao Du, Ji-Long Wang, Wei-Wei Liu, Jin-Xian Yang, Chun-Yang Sun, Rong Sun, Hong-Jun Li, Song Shen, Ying-Li Luo, Xiao-Dong Ye, Yan-Hua Zhu, Xian-Zhu Yang, Jun Wang

Biomaterials· Volume 69
Publisher page

Abstract

Poly(ethylene glycol) (PEG) is usually used to protect nanoparticles from rapid clearance in blood. The effects are highly dependent on the surface PEG density of nanoparticles. However, there lacks a detailed and informative study in PEG density and in vivo drug delivery due to the critical techniques to precisely control the surface PEG density when maintaining other nano-properties. Here, we regulated the polymeric nanoparticles' size and surface PEG density by incorporating poly(ε-caprolactone) (PCL) homopolymer into poly(ethylene glycol)-block-poly(ε-caprolactone) (PEG-PCL) and adjusting the mass ratio of PCL to PEG-PCL during the nanoparticles preparation. We further developed a library of polymeric nanoparticles with different but controllable sizes and surface PEG densities by changing the molecular weight of the PCL block in PEG-PCL and tuning the molar ratio of repeating units of PCL (CL) to that of PEG (EG). We thus obtained a group of nanoparticles with variable surface PEG densities but with other nano-properties identical, and investigated the effects of surface PEG densities on the biological behaviors of nanoparticles in mice. We found that, high surface PEG density made the nanoparticles resistant to absorption of serum protein and uptake by macrophages, leading to a greater accumulation of nanoparticles in tumor tissue, which recuperated the defects of decreased internalization by tumor cells, resulting in superior antitumor efficacy when carrying docetaxel.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Polymer Surface Interaction Studies · Advanced Drug Delivery Systems

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (52)

Show source-provided references
1. Nanomaterials for drug delivery10.1126/science.1219657 ↗
2. PEGylation, successful approach to drug delivery10.1016/S1359-6446(05)03575-0 ↗
3. Polyethylene glycol backfilling mitigates the negative impact of the protein corona on nanoparticle cell targeting10.1002/anie.201309464 ↗
4. Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives10.1002/anie.200902672 ↗
5. Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes
6. Phase I pharmacokinetic study of a weekly liposomal paclitaxel formulation (Genexol-PM) in patients with solid tumors10.1093/annonc/mdp315 ↗
7. Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX (TM)/Doxil (R)) versus conventional doxorubicin for first-line treatment of metastatic breast cancer10.1093/annonc/mdh097 ↗
8. Nanoparticle PEGylation for imaging and therapy10.2217/nnm.11.19 ↗
9. Stealth CD44-targeted hyaluronic acid supramolecular nanoassemblies for doxorubicin delivery: probing the effect of uncovalent pegylation degree on cellular uptake and blood long circulation10.1016/j.jconrel.2014.10.024 ↗
10. Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density10.1016/j.ijpharm.2011.02.039 ↗
11. Biodistribution of long-circulating PEG-grafted nanocapsules in mice: effects of PEG chain length and density10.1023/A:1012248721523 ↗
12. Quantifying the coverage density of poly(ethylene glycol) chains on the surface of gold nanostructures10.1021/nn2038516 ↗
13. The effects of PEG grafting level and injection dose on gold nanorod biodistribution in the tumor-bearing mice10.1016/j.jconrel.2009.06.006 ↗
14. Impact of PEGylation on the biological effects and light heat conversion efficiency of gold nanoshells on silica nanorattles10.1016/j.biomaterials.2013.05.059 ↗
15. Surface polyethylene glycol conformation influences the protein corona of polyethylene glycol-modified single-walled carbon nanotubes: potential implications on biological performance10.1021/nn400409h ↗
16. Controlled PEGylation of monodisperse Fe3O4 nanoparticles for reduced non-specific uptake by macrophage cells10.1002/adma.200701975 ↗
17. PEGylated PRINT nanoparticles: the impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokinetics10.1021/nl302638g ↗
18. Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake10.1021/ja2084338 ↗
19. ‘Stealth’ corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption10.1016/S0927-7765(99)00156-3 ↗
20. Hyaluronan polymer length, grafting density, and surface poly(ethylene glycol) coating influence in vivo circulation and tumor targeting of hyaluronan-grafted liposomes10.1021/nn405839n ↗
21. Determination of polymeric micelles' structural characteristics, and effect of the characteristics on pharmacokinetic behaviors10.1016/j.jconrel.2015.02.017 ↗
22. Pharmacokinetics and biodistribution of nanoparticles10.1021/mp800049w ↗
23. The effect of nanoparticle size, shape, and surface chemistry on biological systems10.1146/annurev-bioeng-071811-150124 ↗
24. Factors affecting the clearance and biodistribution of polymeric nanoparticles10.1021/mp800051m ↗
25. Radioactive 198Au-doped nanostructures with different shapes for in vivo analyses of their biodistribution, tumor uptake, and intratumoral distribution10.1021/nn406258m ↗
26. Investigating the impact of nanoparticle size on active and passive tumor targeting efficiency10.1021/nn500299p ↗
27. Renal clearance of quantum dots10.1038/nbt1340 ↗
28. Vascular permeability in a human tumour xenograft: molecular charge dependence
29. Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles10.1016/j.jconrel.2013.09.013 ↗
30. In vivo tumor targeting of tumor necrosis factor-alpha-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size10.1016/j.ejps.2005.08.002 ↗
31. Mediating tumor targeting efficiency of nanoparticles through design10.1021/nl900031y ↗
32. Accumulation of Sub-100 nm polymeric micelles in poorly permeable tumours depends on size10.1038/nnano.2011.166 ↗
33. Self-assembled biodegradable micellar nanoparticles of amphiphilic and cationic block copolymer for siRNA delivery10.1016/j.biomaterials.2008.07.036 ↗
34. Block copolymerization of ε-caprolactone and 2-methoxyethyl ethylene phosphate initiated by aluminum isopropoxide: synthesis, characterization, and kinetics10.1021/ma061821c ↗
35. Some assembly required10.1126/science.1099988 ↗
36. Block copolymer assembly via kinetic control10.1126/science.1141768 ↗
37. Block copolymer micelles: preparation, characterization and application in drug delivery10.1016/j.jconrel.2005.09.034 ↗
38. Micellar carriers based on block copolymers of poly(ε-caprolactone) and poly(ethylene glycol) for doxorubicin delivery10.1016/j.jconrel.2004.06.003 ↗
39. Evading immune cell uptake and clearance requires PEG grafting at densities substantially exceeding the minimum for brush conformation10.1021/mp400703d ↗
40. Conformational studies of covalently grafted poly(ethylene glycol) on modified solid matrices using X-ray photoelectron spectroscopy10.1021/la9041502 ↗
41. A dense poly(ethylene glycol) coating improves penetration of large polymeric nanoparticles within brain tissue10.1126/scitranslmed.3003594 ↗
42. Influence of polyethylene glycol density and surface lipid on pharmacokinetics and biodistribution of lipid-calcium-phosphate nanoparticles10.1016/j.biomaterials.2013.12.022 ↗
43. Scaling rules for diffusive drug delivery in tumor and normal tissues10.1073/pnas.1018154108 ↗
44. A new concept for macromolecular therapeutics in cancer-chemotherapy - mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs
45. Cancer nanotechnology: application of nanotechnology in cancer therapy10.1016/j.drudis.2010.08.006 ↗
46. Enhanced retention and anti-tumor efficacy of liposomes by changing their cellular uptake and pharmacokinetics behavior10.1016/j.biomaterials.2014.11.010 ↗
47. PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles10.1078/0171-9335-00363 ↗
48. Rational design of polyion complex nanoparticles to overcome cisplatin resistance in cancer therapy10.1002/adma.201303360 ↗
49. Effects of PEG tethering chain length of vitamin E TPGS with a Herceptin-functionalized nanoparticle formulation for targeted delivery of anticancer drugs10.1016/j.biomaterials.2014.01.003 ↗
50. Effect of PEG conformation and particle size on the cellular uptake efficiency of nanoparticles with the HepG2 cells10.1016/j.jconrel.2006.11.028 ↗
51. Tuning PEGylation of mixed micelles to overcome intracellular and systemic siRNA delivery barriers10.1016/j.biomaterials.2014.10.036 ↗
52. The effect of nanoparticle polyethylene glycol surface density on ligand-directed tumor targeting studied in vivo by dual modality imaging10.1021/nn301630n ↗